Cite
HARVARD Citation
Geldof, J. et al. (n.d.). P593 Impact of immunomodulating treatment modalities, active smoking and (repeated) COVID19 vaccination on S-antibody seroconversion in IMID patients. Results of the BELCOMID study: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID). Journal of Crohn's and colitis. pp. i720-i722. [Online].